Isotretinoin
Who holds supplier records for Isotretinoin? 10 organisations hold a current record for Isotretinoin: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Switzerland (1), Italy (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Isotretinoin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/isotretinoin
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Isotretinoin expires 4 Aug 2035. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Isotretinoin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHONGQING HUAPONT PHARMACEUTICAL CO LTDCEPActive DMF 34510, 21653 · latest filing Feb 2020
- HAS Healthcare Advanced Synthesis SASwitzerlandCEP Company GMP cert on recordActive DMF 19918 · latest filing Oct 2006
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 36857 · latest filing Mar 2022
- OLON SPAItalyCEP Company GMP cert on recordActive DMF 7485 · latest filing May 1988
- SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermanyCEP Company GMP cert on recordActive DMF 4676 · latest filing Sept 1982
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordActive DMF 15169, 32517 · latest filing Aug 2018
- APIONEX PHARMA PVT LTDIndiaActive DMF 44474 · latest filing Jul 2026
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 27484 · latest filing Sept 2013
- JIANGXI HENGXIANG PHARMCEUTICAL TECHNOLOGY CO LTDChinaActive DMF 19191 · latest filing Oct 2005
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Isotretinoin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2002-011 - Rev 07 Isotretinoin | May 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2022-205 - Rev 01 Isotretinoin | Jul 2024 | — |
| CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. Chongqing | CN | CEP 2018-219 - Rev 01 Isotretinoin, Process 2 | Dec 2023 | — |
| SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden | DE | R1-CEP 1999-068 - Rev 07 Isotretinoin | Mar 2023 | — |
| OLON S.P.A. Rodano | IT | R1-CEP 1996-082 - Rev 12 Isotretinoin | Apr 2022 | — |
| HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca | CH | R1-CEP 2004-281 - Rev 01 Isotretinoin | Mar 2022 | — |
| SHANGHAI NEW HUALIAN PHARMACEUTICAL CO., LTD. Shanghai | CN | R1-CEP 2008-231 - Rev 02 Isotretinoin | Jun 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (4)
Organisations whose Type II DMFs for Isotretinoin are no longer active. These show a past filing, not current supply.
Show all 4 historical records
- India · Inactive DMF 22616 · filed Jun 2009
- United States · Inactive DMF 15275 · filed Feb 2001
- RP SCHERER NORTH AMERICAInactive DMF 14493 · filed Oct 1999
- Eastman KodakUnited States · Inactive DMF 4887 · filed Mar 1983
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Isotretinoin). The latest listed patent expires 4 Aug 2035. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Isotretinoin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL547).
Chemical identity
- IUPAC name
- (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
- Canonical SMILES
- CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
- InChIKey
- SHGAZHPCJJPHSC-XFYACQKRSA-N
- Synonyms
- 13 cis-retinoic acid, 13-cis-retinoic acid, Absorica, Absorica ld, Accutane, Amnesteem, Claravis, Isotretinoin, Isotretinoina, Isotretinoine, Isotrex, Myorisan
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Retinoid
- Chemical structure
- Retinoids
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Isotretinoin?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Isotretinoin: CHONGQING HUAPONT PHARMACEUTICAL CO LTD, HAS Healthcare Advanced Synthesis SA (Switzerland), Hetero Drugs Limited (India), OLON SPA (Italy), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (Germany), Sun Pharmaceutical Industries Limited (India), APIONEX PHARMA PVT LTD (India) and BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Isotretinoin Drug Master Files are active?
CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 34510, 21653), HAS Healthcare Advanced Synthesis SA (DMF 19918), Hetero Drugs Limited (DMF 36857), OLON SPA (DMF 7485), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH (DMF 4676), Sun Pharmaceutical Industries Limited (DMF 15169, 32517), APIONEX PHARMA PVT LTD (DMF 44474) and BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 27484) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Isotretinoin records mean?
4 organisations have only inactive Type II DMFs for Isotretinoin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Isotretinoin have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Isotretinoin on the EDQM register, including SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), HETERO DRUGS LIMITED Hyderabad (IN), CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. Chongqing (CN), SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBH Minden (DE), OLON S.P.A. Rodano (IT) and HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca (CH) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Isotretinoin?
Yes. The latest patent listed for an approved US product containing Isotretinoin expires 4 Aug 2035, across 59 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Isotretinoin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Isotretinoin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.